Adverum Long Term Debt vs Other Stockholder Equity Analysis

ADVM Stock  USD 6.88  0.24  3.61%   
Adverum Biotechnologies financial indicator trend analysis is way more than just evaluating Adverum Biotechnologies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Adverum Biotechnologies is a good investment. Please check the relationship between Adverum Biotechnologies Long Term Debt and its Other Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.

Long Term Debt vs Other Stockholder Equity

Long Term Debt vs Other Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Adverum Biotechnologies Long Term Debt account and Other Stockholder Equity. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Adverum Biotechnologies' Long Term Debt and Other Stockholder Equity is -0.4. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Adverum Biotechnologies, assuming nothing else is changed. The correlation between historical values of Adverum Biotechnologies' Long Term Debt and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Adverum Biotechnologies are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Long Term Debt i.e., Adverum Biotechnologies' Long Term Debt and Other Stockholder Equity go up and down completely randomly.

Correlation Coefficient

-0.4
Relationship DirectionNegative 
Relationship StrengthVery Weak

Long Term Debt

Long-term debt is a debt that Adverum Biotechnologies has held for over one year. Long-term debt appears on Adverum Biotechnologies balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Adverum Biotechnologies balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Other Stockholder Equity

Most indicators from Adverum Biotechnologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Adverum Biotechnologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.As of the 3rd of December 2024, Sales General And Administrative To Revenue is likely to grow to 17.94, while Selling General Administrative is likely to drop about 31.8 M.
 2021 2022 2023 2024 (projected)
Total Operating Expenses153.6M157.1M127.6M82.0M
Cost Of Revenue4.6M6.5M5.6M5.4M

Adverum Biotechnologies fundamental ratios Correlations

0.570.720.740.940.180.65-0.06-0.610.560.350.66-0.520.940.46-0.190.60.750.820.650.610.940.310.110.430.84
0.570.550.870.3-0.330.980.58-0.850.41-0.20.98-0.320.290.49-0.570.980.590.820.990.980.310.750.640.870.36
0.720.550.50.65-0.290.630.28-0.490.32-0.070.62-0.240.630.68-0.090.560.580.650.580.590.640.16-0.040.440.71
0.740.870.50.55-0.120.880.3-0.890.720.060.89-0.430.550.22-0.410.840.820.950.910.840.560.720.550.760.47
0.940.30.650.550.320.42-0.27-0.330.480.460.42-0.471.00.4-0.030.310.650.660.420.331.0-0.01-0.190.110.82
0.18-0.33-0.29-0.120.32-0.31-0.760.23-0.130.74-0.28-0.230.350.040.45-0.25-0.21-0.1-0.21-0.30.34-0.28-0.15-0.32-0.03
0.650.980.630.880.42-0.310.55-0.80.47-0.181.0-0.340.410.54-0.580.950.650.840.990.960.420.640.510.790.43
-0.060.580.280.3-0.27-0.760.55-0.40.15-0.910.540.31-0.30.21-0.580.530.240.250.480.56-0.280.410.330.490.03
-0.61-0.85-0.49-0.89-0.330.23-0.8-0.4-0.570.03-0.810.34-0.34-0.20.36-0.88-0.7-0.89-0.84-0.88-0.36-0.91-0.73-0.94-0.46
0.560.410.320.720.48-0.130.470.15-0.570.030.47-0.320.48-0.08-0.280.380.920.650.470.360.490.370.110.340.36
0.35-0.2-0.070.060.460.74-0.18-0.910.030.03-0.17-0.530.49-0.030.42-0.140.00.1-0.1-0.170.48-0.08-0.04-0.120.15
0.660.980.620.890.42-0.281.00.54-0.810.47-0.17-0.340.410.54-0.560.960.650.850.990.960.430.650.520.790.43
-0.52-0.32-0.24-0.43-0.47-0.23-0.340.310.34-0.32-0.53-0.34-0.48-0.20.23-0.34-0.38-0.4-0.37-0.32-0.48-0.27-0.23-0.31-0.35
0.940.290.630.551.00.350.41-0.3-0.340.480.490.41-0.480.38-0.010.310.640.660.410.331.00.01-0.170.120.82
0.460.490.680.220.40.040.540.21-0.2-0.08-0.030.54-0.20.38-0.190.520.180.330.510.50.39-0.05-0.120.270.37
-0.19-0.57-0.09-0.41-0.030.45-0.58-0.580.36-0.280.42-0.560.23-0.01-0.19-0.53-0.4-0.3-0.52-0.53-0.02-0.43-0.31-0.41-0.25
0.60.980.560.840.31-0.250.950.53-0.880.38-0.140.96-0.340.310.52-0.530.560.80.960.990.320.780.670.910.39
0.750.590.580.820.65-0.210.650.24-0.70.920.00.65-0.380.640.18-0.40.560.830.640.560.660.440.130.490.63
0.820.820.650.950.66-0.10.840.25-0.890.650.10.85-0.40.660.33-0.30.80.830.870.810.670.660.430.730.65
0.650.990.580.910.42-0.210.990.48-0.840.47-0.10.99-0.370.410.51-0.520.960.640.870.960.430.690.580.820.4
0.610.980.590.840.33-0.30.960.56-0.880.36-0.170.96-0.320.330.5-0.530.990.560.810.960.340.780.670.90.43
0.940.310.640.561.00.340.42-0.28-0.360.490.480.43-0.481.00.39-0.020.320.660.670.430.340.03-0.160.130.82
0.310.750.160.72-0.01-0.280.640.41-0.910.37-0.080.65-0.270.01-0.05-0.430.780.440.660.690.780.030.920.940.2
0.110.64-0.040.55-0.19-0.150.510.33-0.730.11-0.040.52-0.23-0.17-0.12-0.310.670.130.430.580.67-0.160.920.84-0.06
0.430.870.440.760.11-0.320.790.49-0.940.34-0.120.79-0.310.120.27-0.410.910.490.730.820.90.130.940.840.29
0.840.360.710.470.82-0.030.430.03-0.460.360.150.43-0.350.820.37-0.250.390.630.650.40.430.820.2-0.060.29
Click cells to compare fundamentals

Adverum Biotechnologies Account Relationship Matchups

Adverum Biotechnologies fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets222.7M482.6M439.7M308.4M173.0M247.9M
Short Long Term Debt Total32.2M30.7M103.0M106.8M75.0M48.0M
Other Current Liab2.6M9.1M14.8M3.3M2.1M3.9M
Total Current Liabilities19.4M20.9M21.3M32.2M24.9M15.0M
Total Stockholder Equity175.0M434.3M316.2M181.5M83.5M79.3M
Other Liab1.4M48K1.1M1.0M942.3K895.2K
Property Plant And Equipment Net45.8M47.1M119.1M113.9M67.0M37.4M
Net Debt(33.6M)(31.7M)68.8M38.4M36K37.8K
Retained Earnings(385.0M)(502.5M)(648.1M)(802.6M)(919.8M)(873.8M)
Accounts Payable4.1M2.8M1.4M2.2M1.9M1.9M
Cash65.9M62.4M34.2M68.4M75M78.2M
Non Current Assets Total46.9M48.1M122.6M117.8M70.2M39.7M
Cash And Short Term Investments166.0M429.7M305.2M185.6M96.5M91.7M
Common Stock Shares Outstanding6.4M8.5M9.8M9.9M10.1M18.4M
Liabilities And Stockholders Equity222.7M482.6M439.7M308.4M173.0M247.9M
Non Current Liabilities Total28.4M27.3M102.2M94.6M64.6M67.9M
Other Current Assets9.8M9.4M6.2M5.0M6.2M4.4M
Other Stockholder Equity560.7M937.1M965.0M985.7M1.0B567.3M
Total Liab47.8M48.2M123.5M126.9M89.5M46.9M
Property Plant And Equipment Gross24.9M47.1M132.2M130.9M81.5M85.6M
Total Current Assets175.9M434.4M317.1M190.6M102.8M97.6M
Accumulated Other Comprehensive Income(725K)(261K)(714K)(1.5M)(473K)(496.7K)
Property Plant Equipment24.9M27.7M33.1M113.9M130.9M137.5M
Non Currrent Assets Other11K29K250K1.4M1.2M1.3M
Other Assets1.0M1.0M3.5M3.9M4.5M4.7M
Net Tangible Assets175.0M434.3M316.2M181.5M208.7M256.7M
Current Deferred Revenue8.6M12.3M16.0M(6.1M)(7.0M)(6.7M)
Common Stock Total Equity5K6K7K10K11.5K6.5K
Retained Earnings Total Equity(320.5M)(385.0M)(502.5M)(648.1M)(583.3M)(554.1M)
Short Term Investments100.1M367.3M271.0M117.2M21.5M20.4M
Capital Surpluse522.5M560.7M937.1M965.0M1.1B599.6M
Short Term Debt4.0M8.9M3.8M26.5M20.8M21.9M
Common Stock5K6K7K10K11.5K7.4K
Non Current Liabilities Other28.4M27.3M102.2M1.0M1.2M1.1M
Net Invested Capital175.0M434.3M316.2M181.5M83.5M79.3M
Net Working Capital156.5M413.6M295.8M158.3M77.9M74.0M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Adverum Biotechnologies is a strong investment it is important to analyze Adverum Biotechnologies' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adverum Biotechnologies' future performance. For an informed investment choice regarding Adverum Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.95)
Revenue Per Share
0.059
Quarterly Revenue Growth
(0.70)
Return On Assets
(0.30)
Return On Equity
(0.76)
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.